THERESE GRANDLIENARD: Open Payments
NPI 1568822716 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 40 payments from 12 companies in 2025. Trend: 2023 $1,022 · 2024 $1,288 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $209 |
| ABBVIE INC. | 6 | $142 |
| Novo Nordisk Inc | 5 | $108 |
| Lilly USA, LLC | 5 | $100 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| PFIZER INC. | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
| Amgen Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $22 |
Products named: FARXIGA, AIRSUPRA, MOUNJARO, Ozempic, TRELEGY ELLIPTA, QULIPTA, UBRELVY, Kerendia.
Industry payments across FL — which companies pay providers there.
